Scleromyxedema, a therapeutic dilemma
Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed wit...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Series: | Indian Journal of Dermatology |
| Subjects: | |
| Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=215;epage=215;aulast=Salas-Alanis |
| id |
doaj-7341aa6248c541359d99098d18ab72c1 |
|---|---|
| record_format |
Article |
| spelling |
doaj-7341aa6248c541359d99098d18ab72c12020-11-24T23:02:10ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112015-01-0160221521510.4103/0019-5154.152600Scleromyxedema, a therapeutic dilemmaJulio Cesar Salas-AlanisBrayant Martinez-JaramilloMinerva Gomez-FloresJorge Ocampo-CandianiScleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=215;epage=215;aulast=Salas-AlanisPapular mucinosisscleromyxedemathalidomidetreatment failureUVA1 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Julio Cesar Salas-Alanis Brayant Martinez-Jaramillo Minerva Gomez-Flores Jorge Ocampo-Candiani |
| spellingShingle |
Julio Cesar Salas-Alanis Brayant Martinez-Jaramillo Minerva Gomez-Flores Jorge Ocampo-Candiani Scleromyxedema, a therapeutic dilemma Indian Journal of Dermatology Papular mucinosis scleromyxedema thalidomide treatment failure UVA1 |
| author_facet |
Julio Cesar Salas-Alanis Brayant Martinez-Jaramillo Minerva Gomez-Flores Jorge Ocampo-Candiani |
| author_sort |
Julio Cesar Salas-Alanis |
| title |
Scleromyxedema, a therapeutic dilemma |
| title_short |
Scleromyxedema, a therapeutic dilemma |
| title_full |
Scleromyxedema, a therapeutic dilemma |
| title_fullStr |
Scleromyxedema, a therapeutic dilemma |
| title_full_unstemmed |
Scleromyxedema, a therapeutic dilemma |
| title_sort |
scleromyxedema, a therapeutic dilemma |
| publisher |
Wolters Kluwer Medknow Publications |
| series |
Indian Journal of Dermatology |
| issn |
0019-5154 1998-3611 |
| publishDate |
2015-01-01 |
| description |
Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement. |
| topic |
Papular mucinosis scleromyxedema thalidomide treatment failure UVA1 |
| url |
http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=215;epage=215;aulast=Salas-Alanis |
| work_keys_str_mv |
AT juliocesarsalasalanis scleromyxedemaatherapeuticdilemma AT brayantmartinezjaramillo scleromyxedemaatherapeuticdilemma AT minervagomezflores scleromyxedemaatherapeuticdilemma AT jorgeocampocandiani scleromyxedemaatherapeuticdilemma |
| _version_ |
1725637070009925632 |